Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: A strategy to distinguish patients with preeclampsia from matching control individuals

  • Ulrich Pecks
  • Franka Seidenspinner
  • Claudia Röwer
  • Toralf Reimer
  • Werner Rath
  • Michael O. Glocker
Focus: Affinity Mass Spectrometry

DOI: 10.1016/j.jasms.2009.12.013

Cite this article as:
Pecks, U., Seidenspinner, F., Röwer, C. et al. J Am Soc Mass Spectrom (2010) 21: 1699. doi:10.1016/j.jasms.2009.12.013

Abstract

A multifactorial differential analysis of serum proteins using mass spectrometry distinguished samples from pregnant women with severe early-onset preeclampsia (n = 11) from those of control individuals with uneventful pregnancies (n = 13). Serum proteins were fractionated by either their affinities to reversed-phase material coated magnetic beads or by fractionated precipitation. The on-average most abundant ion signals were observed at m/z 9390, 9103, and 8886. The best differentiating ion signals between the two sample groups were found at m/z 13,715, 13,834, and 13,891. The normalized intensities of these ion signals were on-average lower in the preeclampsia group than in the control group. The six ion signal intensities enabled sorting of the individual spectra with high accuracy. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis showed that a protein band migrating just above the 14 kDa marker band contained transthyretin (P02766; Mr (avg.): 13,761). Densitometric analysis of the transthyretin bands showed lower intensities in the preeclampsia samples with respect to those of the controls. Nephelometric analysis of the serum samples determined the mean concentration of transthyretin in the preeclampsia group were lower (0.16 mg/mL; range: 0.13 to 0.20; SD: 0.03) than that in the control group (0.19 mg/mL; range: 0.14 to 0.22; SD: 0.02), substantiating the role of transthyretin concentration differences in the comparison of the two groups. Altogether, our findings support the theory of preeclampsia being a heterogeneous disorder that might be sub-classified by a defined proteome signature in maternal blood using multifactorial analysis of affinity-fractionated serum samples.

Download to read the full article text

Supplementary material

13361_2010_211001699_MOESM1_ESM.doc (54 kb)
Supplementary material, approximately 55 KB.
13361_2010_211001699_MOESM2_ESM.doc (54 kb)
Supplementary material, approximately 55 KB.
13361_2010_211001699_MOESM3_ESM.doc (54 kb)
Supplementary material, approximately 56 KB.
13361_2010_211001699_MOESM4_ESM.doc (49 kb)
Supplementary material, approximately 50 KB.
13361_2010_211001699_MOESM5_ESM.doc (52 kb)
Supplementary material, approximately 53 KB.

Copyright information

© American Society for Mass Spectrometry 2010

Authors and Affiliations

  • Ulrich Pecks
    • 1
  • Franka Seidenspinner
    • 1
    • 2
  • Claudia Röwer
    • 2
  • Toralf Reimer
    • 3
  • Werner Rath
    • 1
  • Michael O. Glocker
    • 2
  1. 1.Department of Obstetrics and Gynecology, Medical FacultyRWTH AachenAachenGermany
  2. 2.Proteome Center Rostock, Department for Proteome Research, Institute of Immunology, Medical Faculty and, Natural Science FacultyUniversity of RostockRostockGermany
  3. 3.Department of Obstetrics and Gynecology, Medical FacultyUniversity of Rostock, Clinic SuedstadtRostockGermany

Personalised recommendations